Genomma Lab Internacional, S.A.B. de C.V. (GNMLF)
OTC Markets OTCPK · USD · Healthcare · Drug Manufacturers - Specialty & Generic
$0.7222 (+0.00%) as of
Key statistics
- Market cap
- 706.13M
- P/E (TTM)
- 7.22
- EPS (TTM)
- 0.1000
- Dividend yield
- 6.14%
- 52-week range
- 0.6850 – 1.0800
- Beta
- 0.13
- Revenue (TTM)
- 17.1B
- Profit margin
- 10.00%
- Volume
- 4.00k
About Genomma Lab Internacional, S.A.B. de C.V.
Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and improvement products, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, infant nutrition, and others. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Mexico City, DF, Mexico
- Employees
- 1,801
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.